Differential inhibition of insulin and islet amyloid polypeptide secretion by intraislet somatostatin in the isolated perfused human pancreas

Pancreas

Volumn 19, Issue 4, 1999, Pages 346-352

  Kleinman, Robert M ^a   Fagan, Shawn P ^b   Ray, Manas K ^b   Adrian, Thomas E ^c   Wong, Helen ^a   Imagawa, David ^a   Walsh, John H ^a   Brunicardi, F Charles ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amyloid; Glucose; Human; Insulin; Islet of Langerhans secretion

Indexed keywords

AMYLIN; GLUCOSE; SOMATOSTATIN; SOMATOSTATIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INFUSION; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN SYNTHESIS; MALE; PANCREAS ISLET; PANCREAS PERFUSION; PRIORITY JOURNAL; PROTEIN SECRETION; SCHOOL CHILD; SOMATOSTATIN RELEASE;

EID: 0032732566     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199911000-00005     Document Type: Article

References (31)

1. Kahn SE, DiAlessio DA, Schwartz MW, et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by B-cells. Diabetes 1990;39:634-8.
2. Stridsberg M, Sander S, Wilander E. Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of B-cell function. Regul Pept 1993;45:363-70.
3. Lukinius A, Wilander E, Westermark GT, et al. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989;32:240-4
4. Inoue K, Hisatomi A, Umeda F, Nawata H. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment. Diabetes 1992;41:723-7.
5. Gedulin B, Cooper GJ, Young AA. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem Biophys Res Commun 1991;180:782-9.
6. De Vroede M, Foriers A, Van De Winkel M, et al. Presence of islet amyloid polypeptide in rat islet B and D cells determines parallelism and dissociation between rat pancreatic islet amyloid polypeptide and insulin content. Biochem Biophys Res Commun 1992;182: 886-93.
7. Kahn SE, Verchere CB, D'Alessio DA, et al. Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway. Diabetologia 1993;36:570-3.
8. Bretherton-Watt D, Ghatei MA, Bloom SR, et al. Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 1989;32:881-3.
9. Brunicardi FC, Druck P, Seymour NE, et al. Selective neurohormonal interactions in islet cell secretion in the isolated perfused human pancreas. J Surg Res 1990;48:273-8.
10. Wong HC, Walsh JH, Yang H, et al. A monoclonal antibody to somatostatin with potent in vivo immunoneutralizing activity. Peptides 1990;11:707-12.
11. Kleinman R, Ohning G, Wong H, et al. The regulatory role of intraislet somatostatin on insulin secretion in the isolated perfused human pancreas. Pancreas 1994;9:172-8.
12. Kleinman R, Gingerich R, Wong H, et al. Use of the Fab fragment for immunoneutralization of somatostatin in the isolated perfused human pancreas. Am J Surg 1994;167:114-9.
13. El Shami AS, Durham AP. Solid phase insulin radioimmunoassay with human serum based calibrators: clinical data and comparison with four other methodologies, Clin Chem 1983;29:1170-1.
14. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994;330:313-8.
15. Stridsberg M, Wilander E. Islet amyloid polypeptide (IAPP): a short review. Acta Oncol 1991;30:451-6.
16. Toshimori H, Narita R, Nakazato M, et al. Islet amyloid polypeptide (IAPP) in the gastrointestinal tract and pancreas of man and rat. Cell Tissue Res 1990;262:401-6.
17. Mitsukawa T, Takemura J, Asai J, et al. Islet amyloid polypeptide response to glucose, insulin and somatostatin analogue administration. Diabetes 1990;39:639-42.
18. Westermark P, Wernstedt C, Wilander E, et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal cat islets. Proc Natl Acad Sci USA 1987;84:3881-5.
19. Koopmans SJ, Radde JK, Krans HM, Barge RM. Biologic action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism. Neth J Med 1992;41:82-90.
20. Leighton B, Cooper GJS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988;335:632-5.
21. Nakazato M, Asai J, Miyazato M, et al. Isolation and identification of islet amyloid polypeptide in normal human pancreas. Regul Pept 1990;31:179-86.
22. Sanke T, Hanabuse T, Nakano Y, et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34: 129-32.
23. Butler PC, Chou J, Carter WB, et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990;39:752-6.
24. Novials A, Sarri Y, Casamitjana R, et al. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 1993;42: 1514-9.
25. O'Brien TD, Butler PC, Westermark P, Johnson KH. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol 1993;30:317-32.
26. Rink TJ, Beaumont K, Koda J. Young A. Structure and biology of amylin. Trends Pharmacol Sci 1993;14:113-8.
27. Fehmann HC, Weber V, Goke R. et al. Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem Biophys Res Commun 1990;167:1102-8.
28. O'Brien TD, Westermark P, Johnson, KH. Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas. Biochem Biophys Res Commun 1990;170:1223-8.
29. Hartter E, Svoboda T, Ludvik B, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 1991;34:52-4.
30. Inoue K, Hisatomi A, Umeda F, Natawa H. Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas. Horm Metab Res 1992;24: 251-3.
31. Mandarino L, Stenner D, Blanchard W, et al. Selective effects of somatostatin-14, -25 and 28 on in vitro insulin and glucagon secretion. Nature 1981;291:76-7.